| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2009 | US20090099147 Non-steroidal progesterone receptor modulators |
| 04/16/2009 | US20090099146 Compositions Containing Sterol-derived Esters |
| 04/16/2009 | US20090099145 Process for Producing a Single-phase Pharmaceutical Preparation for Limiting/Reducing the Risk of Deep Venous Thrombosis in Association with Oral Contraception |
| 04/16/2009 | US20090099144 Oral contraception (long-cycle regimen and 21-days-regimen with 30 mg ethinylestradiol and 2 mg dienogest) without treatment of thrombosis/hemostasis |
| 04/16/2009 | US20090099143 Tetrahydro-indazole cannabinoid modulators |
| 04/16/2009 | US20090099142 Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using same |
| 04/16/2009 | US20090099141 Compositions and methods for treating vitamin d deficiencies |
| 04/16/2009 | US20090099140 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099138 Pharmaceutical combination |
| 04/16/2009 | US20090099137 Anti-Inflammatory Compounds and Uses Thereof |
| 04/16/2009 | US20090099136 Dioxolane thymine phosphoramidates as anti-hiv agents |
| 04/16/2009 | US20090099134 Treatment of dna damage related disorders |
| 04/16/2009 | US20090099133 Isoquinolines Derivatives as Igf-1R Inhibitors |
| 04/16/2009 | US20090099132 Proteasome inhibitors |
| 04/16/2009 | US20090099131 Inhibitors of fatty acid amide hydrolase |
| 04/16/2009 | US20090099130 Methods and compositions for preventing and treating a disease related to glycan dysregulation |
| 04/16/2009 | US20090099128 Composition and method for treating autoimmune disease and mucosal disorder |
| 04/16/2009 | US20090099126 2'-C-(methyl-),2'-O-,3'-O-(benzylidene)<)adenosine; hepatitus C virus prodrugs ofpolymerase enzyme inhibitors; inhibition of HCV NS5B polymerase prevents formation ofthe double-stranded Hepitis C virus RNA; replication-defecctive; viral infections; Flaviviruses; picornavirus; rhinovirus; polio virus |
| 04/16/2009 | US20090099125 Pan cancer oncolytic vectors and methods of use thereof |
| 04/16/2009 | US20090099124 Short interfering rna as an antiviral agent for hepatitis c |
| 04/16/2009 | US20090099123 Antisense microRNA and uses therefor |
| 04/16/2009 | US20090099122 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE EPITHELIAL CELL GROWTH |
| 04/16/2009 | US20090099121 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 04/16/2009 | US20090099120 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 04/16/2009 | US20090099119 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099118 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/16/2009 | US20090099117 RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099116 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099115 A chemically-modified nucleic acid molecule that comprises a sense strand with or without the 3' TT overhang, and a separate antisense strand with or without the 3' TT overhang; pyrimidine modification; cancer |
| 04/16/2009 | US20090099114 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099113 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099112 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099111 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099109 inhibition of p53 transcription by interfering with the activity of a p53 promoter using inhibitory double-stranded RNAs; use of these inhibitory RNAs in the treatment of cancers |
| 04/16/2009 | US20090099108 Oligonucleotide decoys and methods of use |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099106 Quinoline derivatives for modulating dna methylation |
| 04/16/2009 | US20090099105 Content dependent inhibitors of cytidine deaminases and uses thereof |
| 04/16/2009 | US20090099104 Substituted indazoles-o- glucosides |
| 04/16/2009 | US20090099103 Combinations of therapeutic agents for treating cancer |
| 04/16/2009 | US20090099102 Ginkgolides in the Treatment and Prevention of Ovarian Cancer |
| 04/16/2009 | US20090099101 Drugs, foods or drinks with the use of algae-derived physiologically active substances |
| 04/16/2009 | US20090099100 Compositions and methods for treating amyloidosis |
| 04/16/2009 | US20090099099 Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator |
| 04/16/2009 | US20090099094 Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma |
| 04/16/2009 | US20090099088 System for Inhibiting Pathogenicity in the Rice-Blast Fungus Magnaporthe Grisea |
| 04/16/2009 | US20090099084 Treatment |
| 04/16/2009 | US20090099069 Modulators of alpha-synuclein toxicity |
| 04/16/2009 | US20090099062 Pyrvinium For The Treatment of Cancer |
| 04/16/2009 | US20090099061 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090099024 Microcapsules With Acetylene Carbamide-Polyurea Polymers and Formulations Thereof for Controlled Release |
| 04/16/2009 | US20090098636 Fungal cell wall synthesis gene |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098561 Higher-order cellular information processing devices |
| 04/16/2009 | US20090098226 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/16/2009 | US20090098221 Creatine ascorbyl derivatives and methods of use thereof |
| 04/16/2009 | US20090098219 Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith |
| 04/16/2009 | US20090098218 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2 |
| 04/16/2009 | US20090098213 Pain relief and soothing cream and method for making same |
| 04/16/2009 | US20090098211 Solid dosage forms |
| 04/16/2009 | US20090098210 antiproliferative agents, anticancer agents such as paclitaxel particles coated with albumin, and gemcitabine; pancreas cancer |
| 04/16/2009 | US20090098209 Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration |
| 04/16/2009 | US20090098203 Mucoadhesive Tetracycline Formulations |
| 04/16/2009 | US20090098202 Extended Release Formulation |
| 04/16/2009 | US20090098201 Composition and Method for Treatment and Prevention of Atherosclerosis |
| 04/16/2009 | US20090098200 Compositions comprising lipophilic active compounds and method for their preparation |
| 04/16/2009 | US20090098199 Methods of treating gastrointestinal disorders independent of the intake of food |
| 04/16/2009 | US20090098192 Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
| 04/16/2009 | US20090098191 Use of bases to stabilize transdermal formulations |
| 04/16/2009 | US20090098189 Azaindoles as inhibitors of soluble adenylate cyclase |
| 04/16/2009 | US20090098188 Method for delivery of medication using a dissolvable device |
| 04/16/2009 | US20090098185 Method for treating thrombotic disorders using sulfated polysaccharides |
| 04/16/2009 | US20090098181 Triazolopyridazines as kinase modulators |
| 04/16/2009 | US20090098180 Functionalized amino acids and absorbable polymers therefrom |
| 04/16/2009 | US20090098177 Methods and devices for tissue repair |
| 04/16/2009 | US20090098176 Medical devices with triggerable bioadhesive material |
| 04/16/2009 | US20090098174 Heparin coating of biological tissue |
| 04/16/2009 | US20090098173 Topical pain relief product |
| 04/16/2009 | US20090098146 Methods to diagnose a required regulation of trophoblast invasion |
| 04/16/2009 | US20090098145 Methods and compositions for treating ophthalmic conditions via modulation of megalin activity |
| 04/16/2009 | US20090098137 Combinations of therapeutic agents for treating cancer |
| 04/16/2009 | US20090098135 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 04/16/2009 | US20090098133 3-Cyano-2-[3-(2-ethoxy-phenyl)-propanoylamino]-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylic acid tert-butyl ester; cell-cycle specific inducers of apoptosis in cancer cells |
| 04/16/2009 | US20090098127 Agents Capable of Downregulating an MSF-A DEPENDENT HIF-1ALPHA and Use Thereof in Cancer Treatment |
| 04/16/2009 | US20090098125 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098116 Immunogenic compositions for induction of anti-tumor immunity |
| 04/16/2009 | US20090098111 Methods for modulating checkpoint activation through TopBP1 |
| 04/16/2009 | US20090098109 Compositions and Methods For Enhancing Neuronal Plasticity and Regeneration |
| 04/16/2009 | US20090098108 means of delivering the GLP-1 peptide in a sustained manner; obesity related disorders |
| 04/16/2009 | US20090098106 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-kB ACTIVITY |
| 04/16/2009 | US20090098105 Treatment of neurodegenerative diseases by the use of scd4 inhibitors |
| 04/16/2009 | US20090098098 Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use |
| 04/16/2009 | US20090098097 Composition for normalizing blood pressure |